Page last updated: 2024-10-28

lidocaine and Mitochondrial Diseases

lidocaine has been researched along with Mitochondrial Diseases in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J1
Zhu, X1
Yang, S1
Xu, H1
Guo, M1
Yao, Y1
Huang, Z1
Lin, D1

Other Studies

1 other study available for lidocaine and Mitochondrial Diseases

ArticleYear
Lidocaine Attenuates Cognitive Impairment After Isoflurane Anesthesia by Reducing Mitochondrial Damage.
    Neurochemical research, 2019, Volume: 44, Issue:7

    Topics: Anesthetics; Anesthetics, Inhalation; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tum

2019